🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the immunogenicity and safety of G...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-08-25
Trial ID
NCT02184572
Treatments Being Tested
Primary objective: To describe the safety profile of a second dose of ProQu...
Status
Completed
Location
Multiple Locations
Start Date
2007-10-24
Trial ID
NCT00560755
Treatments Being Tested
The purpose of this study is to evaluate consistency in terms of the immune...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-11-09
Trial ID
NCT01702428
Treatments Being Tested
The purpose of this study is to assess the immunogenicity and safety of GSK...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-02-06
Trial ID
NCT01506193
Treatments Being Tested
The objective of this randomized clinical trial is to test whether administ...
Status
Completed
Location
Clinical and Translational Research Center
Start Date
2020-09-22
Trial ID
NCT04475081
Treatments Being Tested
This study aims to provide evidence that co-administration of measles-mumps...
Status
Completed
Location
Research Institute for Tropical Medicine
Start Date
2016-10-13
Trial ID
NCT02880865
Treatments Being Tested
Till now, mortality reports among children below 9 years remains extremely ...
Status
Suspended
Location
Cairo University Hospital
Start Date
2020-07-13
Trial ID
NCT04357028
Treatments Being Tested
The purpose of this study is to evaluate the safety of Sabin Inactivated Po...
Status
Completed
Location
Gaoan Center for Disease Control and Prevention
Start Date
2022-06-13
Trial ID
NCT05432141
Treatments Being Tested
The purpose of this study is to determine whether vYF (investigational vacc...
Status
Recruiting
Location
Investigational Site Number : 3400001
Start Date
2025-07-11
Trial ID
NCT07103148
To evaluate the safety and immunogenicity of GSK Biologicals' live attenuat...
Status
Completed
Location
Multiple Locations
Start Date
2000-11
Trial ID
NCT00388440
Treatments Being Tested